Targeting angiogenesis in chronic liver diseases with portal hypertension: anti-placenta growth factor inhibitor or multikinase inhibitor sorafenib?

Hepatology. 2011 Nov;54(5):1890-1; author reply 1891. doi: 10.1002/hep.24688.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Animals
  • Hepatitis / drug therapy*
  • Humans
  • Hypertension, Portal / drug therapy*
  • Liver Cirrhosis / drug therapy*
  • Male
  • Pregnancy Proteins / antagonists & inhibitors*

Substances

  • Pregnancy Proteins